All Clinical Resources

1 - 12 of 227 results

Uncontrolled Asthma

Podcast Series Sponsored by GlaxoSmithKline; Not for CME/CE Credit


Early Detection of Pancreatic Cancer: The Importance of Primary Care

Podcast Series Sponsored by Immunovia; Not for CME/CE Credit


Man holding his back

Recognizing IBP (inflammatory back pain) vs MBP (mechanical back pain)

An Adaptive Learning Experience Sponsored by Novartis Pharmaceutical Corporation; Not for CME/CE Credit

Axial spondyloarthritis (axSpA) is a chronic and debilitating inflammatory disease primarily affecting the spine and sacroiliac joints. In the United States alone, it is estimated to take 14 years to receive appropriate diagnosis as it's hallmark symptom, inflammatory back pain, can go unnoticed or be misdiagnosed. Due to the challenges in recognizing axSpA, patients are often referred to various healthcare providers in the journey to diagnosis. There is a significant need to increase the proper diagnosis of axSpA among healthcare professionals, especially those that are seeing patients experiencing back pain. Early identification and timely referral to rheumatologists can help mitigate the progressive structural damage and significant patient burden in axSpA patients.


FAQ for ADD & ADHD in Children and Adults: Beyond Stimulants

Controversies around ADHD continue, and higher rates of patients are diagnosed in the U.S., raising concerns about over-diagnosis and treatment. Physicians are often placed in the middle, with the demands of patients for stimulant medications posing a challenge to good care. Conversely, there is more and more evidence for developmentally-based impairments in attention that can respond well to medication. How can we accurately diagnose and treat ADHD with these countervailing forces? A rational, data-based approach is presented including the benefits and side-effects of different approaches, including behavioral strategies. The differential diagnosis is reviewed and cautions around particular "at-risk" populations will be detailed.Guest: Daniel Press, MD

Controversies around ADHD continue, and higher rates of patients are diagnosed in the U.S., raising concerns about over-diagnosis and treatment. Physicians are often placed in the middle, with the demands of patients for stimulant medications posing a challenge to good care. Conversely, there is more and more evidence for developmentally-based impairments in attention that can respond well to medication. How can we accurately diagnose and treat ADHD with these countervailing forces? A rational, data-based approach is presented including the benefits and side-effects of different approaches, including behavioral strategies. The differential diagnosis is reviewed and cautions around particular "at-risk" populations will be detailed.


FAQ for Common Eye Problems Seen in Primary Care

This lecture will update the primary care provider (PCP) on current treatments for diabetic retinopathy, hypertension-related eye conditions, and glaucoma. These three entities are common conditions seen in many of our patients, and a better understanding of the current treatment patterns will improve communication between primary care and ophthalmology. Increasing the specialty knowledge base of the PCPs allows for better co-management and patient education of disease process, management options, and prognosis.Guest: Yvonne I. Chu, MD, MBA

This lecture will update the primary care provider (PCP) on current treatments for diabetic retinopathy, hypertension-related eye conditions, and glaucoma. These three entities are common conditions seen in many of our patients, and a better understanding of the current treatment patterns will improve communication between primary care and ophthalmology. Increasing the specialty knowledge base of the PCPs allows for better co-management and patient education of disease process, management options, and prognosis.


FAQ for Current Approaches to Stroke Prevention in Atrial Fibrillation

Failure to prescribe anticoagulation to prevent stroke in high-risk atrial fibrillation (AF) patients is a persistent and pervasive problem. Despite a multitude of evidence-based clinical practice guidelines, and five effective oral anticoagulants for stroke prevention, at least 30% of these patients remain unprotected. This talk will focus on understanding the root causes of the failure to prevent stroke crisis. The role of antithrombotic therapy, in particular direct oral anticoagulants, will be reviewed. Strategies for implementation of best practices for stoke prevention in AF will be highlighted.Guest: Gregory Piazza, MD, MS

Failure to prescribe anticoagulation to prevent stroke in high-risk atrial fibrillation (AF) patients is a persistent and pervasive problem. Despite a multitude of evidence-based clinical practice guidelines, and five effective oral anticoagulants for stroke prevention, at least 30% of these patients remain unprotected. This talk will focus on understanding the root causes of the failure to prevent stroke crisis. The role of antithrombotic therapy, in particular direct oral anticoagulants, will be reviewed. Strategies for implementation of best practices for stoke prevention in AF will be highlighted.


FAQ for Case Studies in Pulmonary Medicine for the Primary Care Clinician

This talk will focus on several pulmonary topics that often arise in the primary care setting. I have chosen these topics based on scenarios that are common and confusing. For instance, I will review my approach to patients who come to clinic with a diagnosis of asthma for whom the clinical suspicion is low including spirometry and methacholine challenge interpretation. Next, we will review the evidence for using long term oxygen therapy in respiratory patients including the various oxygen delivery systems. I will also cover the approach to chronic cough when the typical therapies have failed to improve symptoms. I will finish with the current evidence and approach to lung cancer screening. If time remains we will answers additional questions from the audience.Guest: Timothy J. Scialla, MD

This talk will focus on several pulmonary topics that often arise in the primary care setting. I have chosen these topics based on scenarios that are common and confusing. For instance, I will review my approach to patients who come to clinic with a diagnosis of asthma for whom the clinical suspicion is low including spirometry and methacholine challenge interpretation. Next, we will review the evidence for using long term oxygen therapy in respiratory patients including the various oxygen delivery systems. I will also cover the approach to chronic cough when the typical therapies have failed to improve symptoms. I will finish with the current evidence and approach to lung cancer screening. If time remains we will answers additional questions from the audience.